Balance Sheet Data

Protalix BioTherapeutics, Inc. (PLX)

$1.45

+0.02 (+1.40%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 37.8117.7938.5538.9922.1838.6144.4051.0558.6967.49
Total Cash (%)
Account Receivables 4.734.7023.444.594.845.576.407.368.46
Account Receivables (%)
Inventories 8.578.1513.0817.9516.8015.6517.9920.6923.7927.35
Inventories (%)
Accounts Payable 5.216.497.226.995.867.578.7010.0111.5113.23
Accounts Payable (%)
Capital Expenditure -0.69-0.63-0.66-1.46-0.63-1.02-1.17-1.35-1.55-1.78
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.